DRUG

afatinib

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for afatinib

Glioblastoma 1

Mediator Outcome Score Tier Lit. status Trial
EGFR glioblastoma 0.220 Mid reproduces known active

Clinical trials

200 registered trials for afatinib

Source: ClinicalTrials.gov